Laura Leticia Rodríguez-Chávez

Laura Leticia Rodríguez-Chávez

Auto-generated profile, based on publicly available information

Laura Leticia Rodríguez-Chávez

Cardiología Adultos, Piso 3, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City 14080, Mexico

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 April 2023 in Global Heart
Verified
Journal Article
Open access
PDF file
AAAlexandra Arias-Mendoza
Alexandra Arias-Mendoza
HGHéctor Gonzalez-Pacheco
Héctor Gonzalez-Pacheco
AÁAmada Álvarez-Sangabriel
Amada Álvarez-Sangabriel
RGRodrigo Gopar-Nieto
Rodrigo Gopar-Nieto
LRLaura Leticia Rodríguez-Chávez
Laura Leticia Rodríguez-Chávez
AAAlfredo Altamirano-Castillo
Alfredo Altamirano-Castillo
Background: Women are underrepresented in acute myocardial infarction (AMI) studies. Furthermore, there is scarce information regarding women with AMI in Latin America. Aims: To describe the presentation, clinical characteristics, risk factor burden, evidence-based care, and in-hospital outcome in a population of women with AMI admitted to a coronary care unit (CCU) in Mexico. Methods: Retrospective cohort study including patients with AMI admitted from January 2006 to December 2021 in a CCU. We identified patients with ST-segment elevation myocardial infarction (STEMI) and non-ST-segment elevation myocardial infarction (NSTEMI). We described demographic characteristics, clinical variables, treatment, and in-hospital outcomes according to gender. Cox regression analysis was used to identify predictors of mortality. Results: Our study included 12,069 patients with AMI, of whom 7,599 had STEMI and 4,470 had NSTEMI. Women represented 19.6% of the population. Women had higher rates of hypertension, diabetes, stroke, and atrial fibrillation than men. For STEMI, women were less likely to receive reperfusion therapy (fibrinolysis; 23.7 vs. 28.5%, p < 0.001 and primary percutaneous coronary intervention (PCI); 31.2 vs. 35.1%, p = 0.001) and had more major adverse events than men: heart failure (4.2 vs. 2.5%, p = 0.002), pulmonary edema (3.4% vs. 1.7%, p < 0.001), major bleeding (2.1% vs. 1%, p = 0.002), stroke (1.3% vs. 0.6%, p = 0.008), and mortality (15.1% vs. 8.1%, p < 0.001). For NSTEMI, women were less likely to undergo coronary angiography or PCI and had more major bleeding and mortality. Multivariate Cox regression analysis revealed that females had an increase in mortality in STEMI and NSTEMI (HR 1.21, CI 1.01–1.47, p = 0.05 and HR 1.39, CI 1.06–1.81, p = 0.01). Conclusion: Real-world evidence from a hospital in a Latin American low- to middle-income country (LMIC) showed that women with AMI had more comorbidities, received less reperfusion treatment or invasive strategies, and had worse outcomes. In STEMI and NSTEMI, female gender represented an independent predictor of in-hospital mortality.

12 February 2025 in Archivos Peruanos de Cardiología y Cirugía Cardiovascular
Verified
Journal Article
Open access
PDF file
ARArturo M. Ruiz-Beltrán
Arturo M. Ruiz-Beltrán
GCGerardo Chacón-Loyola
Gerardo Chacón-Loyola
RBRicardo L. Barajas-Campos
Ricardo L. Barajas-Campos
AAAlejandro Alcaraz-Guzmán
Alejandro Alcaraz-Guzmán
MMManuel A. Montoya-Hernández
Manuel A. Montoya-Hernández
LRLaura Leticia Rodríguez-Chávez
Laura Leticia Rodríguez-Chávez
Objective. To evaluate the predictive ability of traditional risk scores and frailty assessment for 30-day mortality in elderly patients undergoing cardiac surgery. Materials and Methods. A single-center retrospective cohort study was conducted, including elderly patients (≥75 years old) who underwent cardiac surgery between January 2005 and December 2015. EuroSCORE II, STS (Society of Thoracic Surgeons) score, Charlson Comorbidity Index, and Electronic Frailty Index scores were calculated to assess their predictive ability for 30-day mortality using receiver operating characteristic (ROC) curves and corresponding areas under the curve (AUC). Results. A total of 203 patients were included during the study period, of whom 33% underwent isolated coronary bypass surgery. The overall 30- day mortality rate was 17.6%. Patients who died within the first 30 days exhibited higher scores on EuroSCORE II, STS, and the Electronic Frailty Index. The areas under the ROC curves were: EuroSCORE II, 0.74 (95% CI: 0.66-0.81); STS, 0.66 (95% CI: 0.57-0.77); Charlson Comorbidity Index, 0.60 (95% CI: 0.49-0.70); and Electronic Frailty Index, 0.63 (95% CI: 0.52-0.73). Conclusions. In this cohort of elderly patients undergoing cardiac surgery, EuroSCORE II demonstrated the best performance in predicting 30-day mortality.

21 May 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
Hilary Miranda MendozaHilary Miranda Mendoza
Hilary Miranda Mendoza
LALuis M Amezcua-Guerra
Luis M Amezcua-Guerra
GRGustavo Rojas-Velasco
Gustavo Rojas-Velasco
DMDaniel Manzur-Sandoval
Daniel Manzur-Sandoval
JEJennifer Escobar-Alvarado
Jennifer Escobar-Alvarado
MBMalinalli Brianza-Padilla
Malinalli Brianza-Padilla
Background/Objectives: Aortic stenosis (AS) is the most prevalent valvular disease among older adults. Although obstructive sleep apnea (OSA) has been linked to adverse cardiovascular outcomes, its specific impact on patients with severe AS remains unclear. This study aimed to determine the prevalence of OSA and its influence on postoperative recovery following aortic valve replacement. Methods: A prospective case-control study was conducted at the Instituto Nacional de Cardiología Ignacio Chávez. Patients aged 40–80 years with echocardiographically confirmed severe AS were categorized into groups with and without OSA, based on respiratory polygraphy (Apnea–Hypopnea Index [AHI] threshold of >15 events per hour). Clinical, biochemical, echocardiographic, body composition, and hemodynamic parameters were assessed. Daytime sleepiness and sleep quality were evaluated using validated questionnaires. Inflammatory biomarkers were also analyzed. This study was approved by the institutional ethics committee. Results: Of the 30 patients included, 66.6% were diagnosed with OSA. Compared to non-OSA patients, those with OSA had a higher left ventricular mass index (160 vs. 108; p = 0.001), greater postoperative increases in central venous pressure [8 (8–10) vs. 8 (6–8); p = 0.037], and lower mixed venous oxygen saturation within the first 24 h (69.2 vs. 76; p = 0.027). OSA patients also had longer hospital stays (11 vs. 8 days; p = 0.014). Trends toward a heightened subclinical inflammatory state were noted in the OSA group. Conclusions: OSA is frequent and underdiagnosed in patients with severe AS and is associated with more complicated postoperative recovery. Systematic OSA screening is recommended for candidates undergoing aortic valve surgery.